Valuation: Proteome Sciences plc

Market Cap 62.96L 85.34L 73.68L 69.12L 1.18Cr 82Cr 1.2Cr 8.1Cr 3.18Cr 41Cr 3.2Cr 3.13Cr 135.99Cr P/E 2024
-2.95x
P/E 2025 -2.4x
Enterprise Value 2.13Cr 2.89Cr 2.49Cr 2.34Cr 4Cr 275.88Cr 4.06Cr 27Cr 11Cr 138.21Cr 11Cr 11Cr 459.76Cr EV / Sales 2024
4.79x
EV / Sales 2025 5.96x
Free-Float
81.91%
Yield 2024 *
-
Yield 2025 -
1 day-0.55%
1 week-0.55%
Current month-0.28%
1 month-5.53%
3 months+5.59%
6 months-10.70%
Current year-28.20%
1 week 1.6
Extreme 1.6
2
1 month 1.3
Extreme 1.3
2.2
Current year 1.2
Extreme 1.2
4.4
1 year 1.2
Extreme 1.2
4.4
3 years 1.2
Extreme 1.2
8.71
5 years 1.2
Extreme 1.2
8.79
10 years 1.2
Extreme 1.2
15.02
Manager TitleAgeSince
Corporate Officer/Principal - 01/04/2017
Corporate Secretary - 01/08/2017
Director TitleAgeSince
Chairman 73 30/06/2014
Director/Board Member 62 01/01/2010
Director/Board Member 71 01/07/2014
Date Insider Type Main position Quantity % Market Cap.
14/04/23
Vulpes Investment Management Pte Ltd.
BuyCompany 1,00,000 0.0339%
14/04/23
Vulpes Investment Management Pte Ltd.
BuyCompany 1,00,000 0.0339%
06/04/23
Vulpes Investment Management Pte Ltd.
BuyCompany 1,00,000 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
-0.55%-0.55%-39.97%-75.24% 85.34L
-0.79%+1.61%-16.23%+5.18% 19TCr
-0.73%+1.33%-2.60%+11.08% 12TCr
-0.41%-3.84%+6.73%+73.62% 5.96TCr
-0.42%+1.08%+34.00%+70.00% 5.54TCr
-0.71%+1.37%-7.07%-33.92% 4.96TCr
-1.10%+1.27%+9.65%-17.67% 3.35TCr
-2.41%+3.16% - - 3.06TCr
-1.60%-0.79%-7.55%+24.99% 2.43TCr
-0.80%-1.57%+40.78%-11.77% 2.44TCr
Average -0.95%+0.51%+1.97%+5.14% 5.84TCr
Weighted average by Cap. -0.83%+0.81%-0.60%+15.51%

Financials

2024 2025
Net sales 48.87L 66.25L 57.19L 53.66L 91.89L 63Cr 93.16L 6.29Cr 2.46Cr 32Cr 2.49Cr 2.43Cr 105.56Cr 37.56L 50.92L 43.96L 41.24L 70.62L 49Cr 71.6L 4.83Cr 1.89Cr 24Cr 1.91Cr 1.87Cr 81Cr
Net income -34.06L -46.17L -39.86L -37.39L -64.04L -44Cr -64.93L -4.38Cr -1.72Cr -22Cr -1.73Cr -1.7Cr -74Cr -30.61L -41.49L -35.82L -33.61L -57.56L -40Cr -58.35L -3.94Cr -1.54Cr -20Cr -1.56Cr -1.52Cr -66Cr
Net Debt 1.34Cr 1.82Cr 1.57Cr 1.47Cr 2.52Cr 173.6Cr 2.55Cr 17Cr 6.76Cr 87Cr 6.82Cr 6.67Cr 289.32Cr 1.5Cr 2.03Cr 1.75Cr 1.65Cr 2.82Cr 194.28Cr 2.86Cr 19Cr 7.56Cr 97Cr 7.63Cr 7.46Cr 323.77Cr
Logo Proteome Sciences plc
Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.
Employees
32
Date Price Change Volume
17/26/17 GBX 1.795 -0.55% 23,304
14/26/14 GBX 1.805 +0.28% 10,65,455
13/26/13 GBX 1.800 0.00% 1,09,677
12/26/12 GBX 1.800 +1.41% 250
11/26/11 GBX 1.775 -1.66% 2,02,479